Endoscopic diagnosis and classification of reflux esophagitis: Are we there yet?

Boyce, H.

doi:10.1016/s0016-5107(02)70142-9

Cited by 9 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Oesophageal function testing, which can be used to aid diagnosis, includes endoscopy, manometry and 24‐hour pH monitoring. The investigation of first choice is endoscopy because it allows direct observation of oesophageal damage and enables detection of Barrett's oesophagus 20 . One of the major differences between Asia and the West is the age at which endoscopy is used before any treatment is given.…”

Section: Introductionmentioning

confidence: 99%

Review article: prevalence and epidemiology of gastro‐oesophageal reflux disease in Japan

Fujimoto

2004

Aliment Pharmacol Ther

View full text Add to dashboard Cite

Summary The prevalence of gastro‐oesophageal reflux disease (GERD) in Asian populations is reported to be lower than that in Western populations. However, recent epidemiological studies suggest that the incidence of the disease is increasing, especially in Japan. Endoscopic studies show that the overall prevalence of reflux oesophagitis among the adult population in Japan is in the region of 14–16%. This is similar to the figure reported in Western countries. The increasing prevalence in Japan may be due to a number of factors including increasing awareness of the condition and improved diagnostic techniques. The majority of the diagnosed cases in Japan are mild and these account for the increase in prevalence of the condition. In contrast to the West, where the condition is more prevalent in male members of the population, there is a high incidence of GERD in elderly females in Japan. The increased incidence of kyphosis and osteoporosis in this population may lead to the development of hiatus hernia, a condition known to exacerbate the development of reflux disease. Furthermore, Japanese patients with endoscopically diagnosed GERD appear to be less likely to complain of typical reflux symptoms, such as heartburn and acid reflux than their Western counterparts. In view of the known relationship between asymptomatic GERD and the development of oesophageal cancers there is a strong case for increased vigilance in the detection of GERD in the Japanese population.

show abstract

Section: Introductionmentioning

confidence: 99%

Review article: prevalence and epidemiology of gastro‐oesophageal reflux disease in Japan

Fujimoto

2004

Aliment Pharmacol Ther

View full text Add to dashboard Cite

show abstract

Should catheter atrial fibrillation ablation be considered as a 'high bleeding risk' intervention?

Bun¹,

Laţcu²,

Saoudi³

2013

Europace

View full text Add to dashboard Cite

Management of antithrombotic therapy in patients undergoing electrophysiological device surgery

Zacà¹,

Marcucci²,

Parodi³

et al. 2015

Europace

View full text Add to dashboard Cite

The aim of this review is to formulate practical recommendations for the management of antithrombotic therapy in patients undergoing cardiac implantable electronic device (CIED) surgery by providing indications for a systematic approach to the problem integrating general technical considerations with patient-specific elements based on a careful evaluation of the balance between haemorrhagic and thromboembolic risk. Hundreds of thousands patients undergo implantation or replacement of CIEDs annually in Europe, and up to 50% of these subjects receive antiplatelet agents or oral anticoagulants. The rate of CIED-related complications, mainly infective, has also significantly increased so that transvenous lead extraction procedures are, consequently, often required. Cardiac implantable electronic device surgery is peculiar and portends specific intrinsic risks of developing potentially fatal haemorrhagic complications; on the other hand, the periprocedural suspension of antithrombotic therapy in patients with high thromboembolic risk cardiac conditions may have catastrophic consequences. Accordingly, the management of the candidate to CIED surgery receiving concomitant antithrombotic therapy is a topic of great clinical relevance yet controversial and only partially, if at all, adequately addressed in evidence-based current guidelines. In spite of the fact that in many procedures it seems reasonably safe to proceed with aspirin only or without interruption of anticoagulants, restricting to selected cases the use of bridging therapy with parenteral heparins, there are lots of variables that may make the therapeutic choices challenging. The decision-making process applied in this document relies on the development of a stratification of the procedural haemorrhagic risk and of the risk deriving from the suspension of antiplatelet or anticoagulant therapy combined to generate different clinical scenarios with specific indications for optimal management of periprocedural antithrombotic therapy.

show abstract

Endoscopic diagnosis and classification of reflux esophagitis: Are we there yet?

Cited by 9 publications

References 9 publications

Review article: prevalence and epidemiology of gastro‐oesophageal reflux disease in Japan

Review article: prevalence and epidemiology of gastro‐oesophageal reflux disease in Japan

Should catheter atrial fibrillation ablation be considered as a 'high bleeding risk' intervention?

Management of antithrombotic therapy in patients undergoing electrophysiological device surgery

Contact Info

Product

Resources

About